Access to biologic therapy, such as omalizumab, is a significant barrier for CSU patients in Latin America, despite high disease knowledge. Participants in the pilot program had high baseline ...
Strong gold price to have material impact on economics: Since the Updated Scoping Study was released in May 2025 using a gold ...
Review of Operations for the Quarter ended 31 December 2025 and update on the Formal Sale Process (‘FSP’) Kore Potash (AIM: KP2, ASX: KP2, JSE: KP2, A2X: KP2), the potash development company with 97% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results